HHS Selects Drugs for Medicare Price Negotiation
Biden Administration introduces price regulation to the pharmaceutical industry.
Patents Do Not Bar Public Pharma Policies
Merck misconstrues patent law in its recent Takings Clause challenge to Medicare’s price negotiation program.
FDA’s Role in Access to Reproductive Health Care
Recent abortion pill litigation underscores the significance of calls to make birth control pills available over the counter.
Regulating to Improve Methadone Access
Scholars identify avenues to curb regulatory barriers to substitution therapy.
Drug Safety, or Overregulation of Reproductive Health?
Scholar calls for FDA to remove stringent restrictions on medication abortion.
FDA, Not a Federal Judge, Should Decide on Abortion Drugs
Anti-abortion advocates take aim at FDA approval and regulation of the abortion drug mifepristone, threatening access nationwide.
Regulating Supervised Consumption Services
Experts discuss the role of regulations in monitoring experimental overdose prevention programs.
The ADA’s Power to Reduce Overdose Deaths in Prison
Scholars argue that the ADA’s protections could prevent overdose deaths for people in prison.
Hallucinate, Medicate, and Regulate
In this week’s Saturday Seminar, experts discuss ways to regulate psychedelics for medicinal use.
High Hopes for FDA Regulation of CBD Products
FDA regulation of CBD products faces new challenges as the market develops.
Value-Pricing Prescription Drugs
Scholar argues that reducing pricing for prescription drugs may increase innovation.
Pennsylvania Lawmakers Restrict Access to Fentanyl Test Strips
Pennsylvania law prevents people who use drugs from testing for fentanyl and avoiding overdoses.